Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease - Science Magazine 19-Jun-2020

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease - Science Magazine

With no vaccine or proven effective drug against the virus that causes coronavirus disease 2019 (COVID-19), scientists are racing to find clinical antiviral treatments. A promising drug target is the viral main protease Mpro, which plays a key role in viral r…